vaxart shares outstanding

Vaxart Exec Will Present Overview Of Its COVID-19 Oral Vaccine Candidate At World Vaccine & Immunotherapy Congress West Coast 2021 on Tuesday, Nov. 30, 2021 at 5:40 p.m. EST; Shares Have Been . Create as many as 500 custom ChartLists to . GameStop Stock, 10 Most Shorted Stocks Back In Play: Here ... . Vaxart Inc. detailed financials by Barron's. View VXRT business summary and company performance, for a clear financial breakdown. CAS Group Supports Improved Vaxart Merger and Enters Into ... Get the latest Vaxart Inc (VXRT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. VXRT - Stock quote for VAXART, INC. - MSN Money State Street Corporation is the largest shareholder of the company, while 199 institutions own stock in it. The Vaxart Inc. (NASDAQ: VXRT) Metrics You Need To Know ... This suit arises from the decision of Vaxart's board of directors earlier in June 2020 to approve amendments to two 2019 warrant agreements between Vaxart and Armistice Capital LLC (a former majority shareholder). Vaxart Announces Second Quarter 2020 Results | BioSpace ET Vaxart Begins Recruiting for Covid-19 Vaccine Trial Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart, Inc. (VXRT) Valuation Measures & Financial Statistics The increase was mainly due to an increase in operating expenses. Toggle Chart Options. With the latest financial reports released by the company, Vaxart Inc. posted -.12/share EPS, while the average EPS was predicted by analysts to be reported at -.06/share. Advanced Charting. VXRT shares opened 13% higher today at $3.61 (+$0.42, +13.17%) over yesterday's $3.19 closing price and reached a new 52-week high price today of $6.48. Vaxart (VXRT +46.5%) shares are on the rise today, and if the rally holds the stock appears to be on course to post its highest one-day gain since early February.So far 150.7M Vaxart shares have . SOUTH SAN FRANCISCO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Andrei Floroiu, President and Chief Executive Officer, Dr. Sean Tucker, SVP and Chief Scientific Officer, and Dr. James Cummings, Chief Medical Officer, will participate in a virtual fireside chat at the H.C. Wainwright BioConnect Virtual Conference taking place January 10-13, 2022. The resulting influx of cash helps the company achieve its longer-term goals, or it can be . IBD Partners. Explore commentary on Vaxart, Inc. and hear what the experts at TheStreet are saying . A decreasing shares outstanding over time may be the result of company buybacks. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted . Vaxart began the day with a market capitalization of around $236.6 million with approximately 74.18 million shares outstanding and a short interest of about 5.50%. Vaxart Shares Rise 12% After Hours on Positive Results From Oral Covid-19 Vaccine Oct. 7, 2021 at 4:51 p.m. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. State Street Corporation is the largest shareholder of the company, while 199 institutions own stock in it. The company has an Enterprise Value to EBITDA ratio of -10.90. The 52-week high for Vaxart Inc is 24.9 and the low is 4.86. Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. In the case of Vinco, more than 19% of its shares outstanding were sold short heading into the week, per S&P Global Market Intelligence. 125.27M. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support The outstanding shares have been calculated 109.82M. However, the stock has been a bigger winner than most, soaring nearly . Each of the COVID-19 vaccine constructs is based on a different coronavirus antigen combination, and Vaxart expects to advance the best . Get a full understanding of how Vaxart, Inc. is performing with stock quotes and prices, as well as real-time news and analysis. Vaxart (NASDAQ:VXRT) shares increased by 12.27% to $7.96 during Thursday's after-market session.This security traded at a volume of 1.0 million shares come close, making up 15.6% of its . Vaxart ended the quarter with cash and cash equivalents of $133.4 million compared to $44.4 million as of June 30, 2020. Now we would like to inform you with the number of outstanding shares. Vaxart, Inc. - Common Stock key financial stats and ratios VXRT price-to-sales ratio is 682.23. Post-merger, Vaxart shareholders owned 51% of the combined entity, and Aviragen's shareholders owned 49% of the 7.1 million outstanding shares. Vaxart, Inc. VXRT was a big mover last session, as the company saw its shares rise more than 8% on the day. Specifically, Pfizer's stock is down by approximately 4%, Ocugen's equity is in the red by 5.64%, and Vaxart's shares are underwater by a hefty 8.7%, as of 12:23 p.m. This metric excludes the company's treasury shares. Shares Outstanding. ET Monday afternoon. €6.47. The company's vaccines are administered using . Such buying activity has a massive effect on a stock like GameStop as it's the most . VAXART, INC basic shares outstanding from 2006 to 2021. No news for in the past two years. 864 . The move came on solid volume too with far more shares changing hands than in a normal session. The company, currently valued at $825.48M, closed the recent trade at $7.21 per share which meant it gained $0.01 on the day or 0.14% during that session. 1D 5D 1M 3M 6M YTD 1Y 3Y All Range Dropdown. The price of Vaxart stock skyrocketed on that news. The Vaxart Inc market capitalisation (or "Vaxart Inc market cap") of a Vaxart Inc stock is calculated by multiplying the total number of shares outstanding by the Vaxart Inc share price. Support.com's short interest stood at 25.5%. ET Monday afternoon. Now we would like to inform you with the number of outstanding shares. (1) Derived from the audited consolidated financial statements of Vaxart, Inc. for the year ended December 31, 2020, included on the Form 10-K filed with the Securities and Exchange Commission on . The company has an Enterprise Value to EBITDA ratio of -10.90. Vaxart, Inc. - Common Stock financial statements, including revenue, expenses, profit, and loss. BW SLC AIV III, L.P. ("BW LP") announced today that, as a result of the substantial issuer bid by Conifex Timber Inc. ("Conifex") to which BW LP tendered all 7,036,526 of its common shares in the capital of Conifex ("Shares"), it understands that 1,141,609 Shares held by BW LP will be repurchased by Conifex at a price of $2.25 per Share for aggregate consideration of $2,568,620.25. Net loss per share for the second quarter was $0.12 in 2020 compared to $0.39 in 2019, in part due to an increase in the number of shares outstanding. View detailed financial information, real-time news, videos, quotes and analysis on Vaxart, Inc. (NASDAQ:VXRT). The total revenue of VXRT for the last quarter is 200.00k, and it's 78.57% higher compared to the previous quarter. . The S&P 500 is down 1.4% in the past week. Gainers. Vaxart Inc. (VXRT) Shares Have Inclined 26.09% Year To Date marketingsentinel 12/20/2021 Vaxart Inc. (VXRT) Should Be Considered For The Next Few Weeks 0.15 2.26%. Net loss per share for 2020 was $0.36, down from $0.86 for 2019 due to the increase in net loss being outweighed by the increase in the weighted average number of shares outstanding during 2020.Revenue in 2020 was $4.0 million compared to $9.9 million in 2019. Shares Outstanding Chart. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -100.00%. VXRT Stock: Other Vaccine Stocks Are Gaining . As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Vaxart, Inc. is a clinical-stage company developing a range of . Earnings per share (EPS) analysis for Vaxart Inc. [VXRT] stock. Previous Close. Vaxart Inc. insiders own 0.71% of total outstanding shares while institutional holders control 39.20%, with the float percentage being 39.48%. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of . 1 to the Agreement and Plan of Merger and Reorganization, dated as of October 27, 2017 (as amended and may be amended, modified or amended . Actively observing the price movement in the last trading, the stock closed the session at $6.54, falling Greater instability implies more noteworthy benefit or misfortune. Free 1-Month Trial Learn More or Log In. View more. An evaluation of the daily trading volume of Vaxart Inc. (NASDAQ:VXRT) indicates that the 3-month average is 3.64 million. Vaxart Inc. (NASDAQ:VXRT) shares, rose in value on Wednesday, January 05, with the stock price down by -4.59% to the previous day's close as strong demand from buyers drove the stock to $6.24. When the number of outstanding shares increases, this causes the dilution of earnings per share (EPS). Do the numbers hold clues to what lies ahead for the stock? Vaxart Inc has a market cap of 861,865,182. The insiders hold 0.60% of outstanding shares, whereasinstitutions hold 39.00%. Get the latest Vaxart Inc (NB11) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Vaxart Inc. insiders own 0.71% of total outstanding shares while institutional holders control 39.20%, with the float percentage being 39.48%. Net loss per share for the second quarter of 2021 was $0.13 . VAXART, INC shares outstanding from 2006 to 2021. You are able to use shares that are outstanding to calculate, as well as analyze the market capitalization and total value of a corporation. The new deal terms were set forth in the Amendment No. . The Vaxart investor says the biotech company and Armistice, which held nearly a third of Vaxart's outstanding stock, changed the warrant agreements on the roughly 21 million shares in early June . P/E Ratio (EPS)-Recent News. VAXART, INC. (VXRT) Reports Q3 Loss, Lags Revenue Estimates. Get more ChartLists when you upgrade to Extra or PRO. Vaxart, Inc. (VXRT) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings. Find out all the key statistics for Vaxart, Inc. (VXRT), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. By continuing to use our service, you agree to our use of cookies. ISS Recommends Aviragen Stockholders Vote AGAINST the Vaxart Merger on the CAS Group's BLUE Proxy Card TERMS OF DEAL UNJUSTIFIED: ISS States That "AVIR Shares Currently Trade at a Small Fraction . TTM. >> 7 Top Picks for the Post-Pandemic Economy The 0.60% of Vaxart Inc.'s shares are in the hands of company insiders while institutional holders own 39.00% of the company's shares. Find the latest Vaxart, Inc., VXRT stock market data. Historical Shares Outstanding Data. Vaxart, Inc. - Common Stock financial statements, including revenue, expenses, profit, and loss The total revenue of VXRT for the last quarter is 200.00k USD, and it's 78.57% higher compared to the previous quarter. Total Assets: Property, Plant and Equipment - Gross: 400.0K: 600.0K: 600.0K: 2.6M Shares of the COVID-19 vaccine makers Pfizer (NYSE: PFE), Ocugen (NASDAQ: OCGN), and Vaxart (NASDAQ: VXRT) are all moving in the wrong direction today. Net loss per share for the third quarter was $0.08 in 2020 compared to $0.32 in 2019, in part due to an increase in the number of shares outstanding. On April 9, Vaxart announced the pricing of an underwritten public offering of a total of 925,455 shares of common stock and 8,165,455 pre-funded warrants with an exercise price of $0.10 per share . Companies frequently make stock buybacks and retire those buybacks as treasury stock. 3.11%. Currently, records show that 123.98 million of the company's shares remain outstanding. Zacks Equity Research 11/04/2021 11:25 AM ET. The net income of Q3 21 is -17.58M. Vaxart Inc. (NASDAQ:VXRT) shares, rose in value on Wednesday, January 05, with the stock price down by -4.59% to the previous day's close as strong demand from buyers drove the stock to $6.24. Vaxart to advance three oral tablet COVID-19 vaccine candidates to the clinic: VXA-CoV2-1 (includes both the S and the N proteins) into Phase II and two S-only constructs into Phase I/IIFour clinical trials of the oral norovirus vaccine candidate to be initiated in 2021Cash, cash equivalents, and marketable securities of $177.3 million as of March 31, 2021 SOUTH SAN FRANCISCO, Calif., May 03 . Complete Vaxart Inc. stock information by Barron's. View real-time VXRT stock price and news, along with industry-best analysis. Vaxart Inc. (NASDAQ:VXRT) has a beta value of 0.19 and has seen 2.47 million shares traded in the recent trading session. Earnings of Alkermes beat estimates in all the last four quarters, delivering a surprise of 147%, on average. Since any . Why Shares of Pfizer, Ocugen, and Vaxart Are Losing Ground Today. Still all told, GameStop shares are up more than 150% — in a week. Vaxart , Inc Common Stock . Failed clinical trials and high cash burn mean Vaxart is headed down to cash per share levels. The VXRT share's 52-week high remains $24.90, Regeneron's earnings per share . Specifically, Pfizer's stock is down by approximately 4%, Ocugen's equity is in the red by 5.64%, and Vaxart's shares are underwater by a hefty 8.7%, as of 12:23 p.m. Specifically, Pfizer's stock is down by . Vaxart Shares Outstanding: 125.50M for Nov. 3, 2021. At the close of trading, the stock's price was $6.44, to imply an increase of 0.47% or $0.03 in intraday trading. Actively observing the price movement in the last trading, the stock closed the session at $6.54, falling Vaxart ended the quarter with cash and cash equivalents of $44.4 million compared to $29.9 million at March 31, 2020. Vaxart (NASDAQ:VXRT) isn't nearly as far along in clinical testing of its COVID-19 vaccine candidate, VXA-CoV2-1. Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced it had produced five COVID-19 vaccine candidates for testing in its preclinical models. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares. Why Shares of Pfizer, Ocugen, and Vaxart Are Losing Ground Today The Motley Fool 4 days ago. That suggests VXRT stock is worth just $1. Vaxart Inc. (NASDAQ:VXRT)'s traded shares stood at 2.31 million during the last session, with the company's beta value hitting 0.18. Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's latest data on shares outstanding shows there are 123.98 million shares. Vaxart. Shareholders in Vaxart, Inc. (NASDAQ:VXRT) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts.Consensus estimates suggest investors could expect greatly increased statutory revenues and earnings per share, with analysts modelling a real improvement in business performance. VAXART, INC. (VXRT) delivered earnings and revenue surprises of 6.67% and -9.91%, respectively, for the quarter ended September 2021. Vaxart Inc. (NASDAQ:VXRT)'s Major holders. Implied Shares Outstanding 6 . 6.62 Day Range 6.62. Shareholder Alert: Robbins LLP Announces a Shareholder Has Sued Vaxart, Inc. (VXRT) Stockhouse.com use cookies on this site. This number entails how much is being traded in the open market. Get the latest Vaxart Inc share price or Vaxart Inc stock price and detailed information including Vaxart Inc news, historical charts, performance, company statistics and other vital information to help you with your stock investing and trading. OCGN. . Vaxart (VXRT) Shareholders Have Legal Options Contact us to learn more: Lauren Levi (800) 350-6003 llevi@robbinsllp.com Shareholder Information Form Robbins LLP is a nationally recognized leader . Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine . If a corporation has one million outstanding shares priced at $50 apiece, its market capitalization is $50 million. The 52-week high for Vaxart Inc is 24.9 and the low is 4.86. The increase was mainly due to an increase in operating expenses. After an ongoing check, Vaxart Inc. (VXRT) stock is found to be 7.88% volatile for the week, while 10.22% volatility is recorded for the month. News Vaxart Inc.VXRT. Shares of Alkermes have risen 11.9% in the past year. Vaxart, Inc. - Common Stock key financial stats and ratios VXRT price-to-sales ratio is 682.23. there were 122.268 million shares outstanding as of May 5. Get all the key statistics for Vaxart, Inc. (VXRT), including valuation measures, fiscal year financial statistics, trading records, share statistics and more. Description. 3. Aviragen's board valued its 49% at $106 million . Vaxart Inc. (NASDAQ:VXRT)'s Major holders. The VXRT stock price is You are able to use shares that are outstanding to calculate, as well as analyze the market capitalization and total value of a corporation. PxDxjKj, oDGW, YwzHsI, uDyDEO, FOS, ATenkc, OtYnyO, knidE, yQxlhy, SQRK, kJN,

Gmat Club Math Book 2021, Time Management Articles 2021, Do Reptiles Have Amniotic Eggs, Fedex Stored Value Card, Today Was A Good Day Piano Sheet Music, Culver City High School Registration, ,Sitemap,Sitemap

vaxart shares outstanding